期刊文献+

从噬菌体展示随机肽库中定量筛选人血清白蛋白黏附肽

Quantitative screening human serum albumin binding peptides using phage display random peptide library
下载PDF
导出
摘要 人血清白蛋白作为长效化载体蛋白可用于改善蛋白质药物的半衰期。除了以人血清白蛋白融合方式提高蛋白质药物的半衰期,黏附人血清白蛋白也已成为改善蛋白质药物药代动力学特性的策略。本研究以人血清白蛋白为靶分子,利用噬菌体表面展示技术对随机七肽库进行生物淘选,挑取噬菌体单克隆进行特异性鉴定。经4轮生物淘选后回收率和选择比都有了一定提高,使用滴度检测方法对所挑选的噬菌体阳性克隆进行了相对亲和力的测定,并经过DNA测序得到了4个特异性黏附肽HSA-1、HSA-5、HSA-6和HSA-10的序列。将此类多肽插入到蛋白质药物上,将有助于提高蛋白质药物在血清中的半衰期,从而达到长效目的。 Human serum albumin(HSA) is a long-acting carrier protein in drug design for prolonging the half-lives of protein drugs.Not only HSA fusion protein but also HSA binding protein has become general strategy for improving the pharmacokinetics of proteins.Using Ph.D.-7 phage display random peptide library,we identified a series of peptides that specially bind to HSA.The recovery yield and specificity ratio have been defined as the selection criteria in the panning process.After 4 rounds selection,the recovery yield and specificity ratio of human albumin binding peptide are both having a certain increase.The relative affinities of the four individual clones were assayed with the method of the measurement of phage titres.Four HSA binding peptides HSA-1,HSA-5,HSA-6 and HSA-10 were also characterized by DNA sequencing,which were inserted into the protein drugs to prolong their half-lives in the serum.
出处 《大连工业大学学报》 CAS 北大核心 2010年第4期251-254,共4页 Journal of Dalian Polytechnic University
基金 辽宁省教育厅重点实验室项目(2008S015)
关键词 人血清白蛋白 药物长效化 噬菌体展示随机肽库 特异性黏附肽 human serum albumin long life drug phage display random peptide library human serum albumin binding peptides
  • 相关文献

参考文献7

  • 1SUBRAMANIAN M G,FISCELLA M,LAMOUSE-SMITH A,et al.Albinterferon alpha-2b:a genetic fusion protein for the treatment of chronic hepatitis C[J].Nature Biotechnology,2007,25(12):1411-1419.
  • 2石屹峰,边蕾.以人血清白蛋白为载体的长效蛋白质药物的研究进展[J].中国医药生物技术,2008,3(6):454-456. 被引量:15
  • 3SMITH G P.Fliamentous fusion phage:novel expression vectors that display cloned antigens on the virion surface[J].Science,1985,228:1315-1317.
  • 4KEHOE J W,KAY B K.Filamentous phage display in the new millennium[J].Chemical Reviews,2005,105(11):4056-4072.
  • 5DYSON M R,GERMASCHEWSKI V,MURRAY K.Direct measurement via phage titre of the dissociation constants in solution of fusion phage-substrate complexes[J].Nucleic Acids Research,1995,23:1531-1535.
  • 6DENNIS M S,ZHANG Min,KADKHODAYAN M,et al.Albumin binding as a general strategy for improving the pharmacokinetics of proteins[J].The Journal of Biological Chemistry,2002,277(38):35035-35043.
  • 7HOLT L J,BASRAN A,JONES K,et al.Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs[J].Protein Engineering Design and Selection,2008,21(5):283-288.

二级参考文献15

  • 1[2]Subramanian GM,Fiscella M,Lamouse-Smith A,et al.Albinterferon alpha-2b:a genetic fusion protein for the treatment of chronic hepatitis C.Nat Biotechnol,2007,25(12):1411-1419.
  • 2[4]Otagiri M.A molecular functional study on the interactions of drugs with plasma proteins.Drug Metab Pharmacokinet,2005,20(5):309-323.
  • 3[5]Kragh-Hansen U,Chuang VT,Otagiri M.Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.Biol Pharm Bull,2002,25(6):695-704.
  • 4[6]Nguyen A,Reyes AE 2nd,Zhang M,et al.The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin.Protein Eng Des Sel,2006,19(7):291-297.
  • 5[7]Osborn BL,Sekut L,Corcoran M,et al.Albutropin:a growth hormone-albumin fusion with improved pharmacokinetics and pharruacodynamies in rats and monkeys.Eur J Pharmacol,2002,456(1/3):149-158.
  • 6[8]Halpern W,Riecobene TA,Agostini H,et al.Albugranin,a recombinant human granulocyte colony stimulating factor (G-CSF)genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys.Pharm Res,2002,19(11):1720-1729.
  • 7[9]Osborn BL,Olsen HS,Nardelli B,et al.Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.J Pharmacol Exp Ther,2002,303(2):540-548.
  • 8[10]Melder RJ,Osborn BL,Riccobene T,et al.Pharmacokineties and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice.Cancer Immunol Immanother,2005,54(6):535-547.
  • 9[11]Bagglo LL,Huang Q,Brown TJ,et al,A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety,gastrointestinal motility,and glucose homeostasis.Diabetes,2004,53(9):2492-2500.
  • 10[12]Bloomgarden ZT.Gut-derived incretin hormones and new therapeutic approaches.Diabetes Care,2004,27(10):2554-2559.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部